Curatia Medical is a healthcare and manufacturing company based in Sunnyvale, CA, U.S.A. Founded in 2013, it operates with a manufacturing facility in Suzhou, China. The company has gained recognition as a global leader in vascular access devices. With a sales network spanning over 30 countries across North America, Europe, South America, and Asia, Curatia Medical is dedicated to developing, manufacturing, and selling disposables in interventional cardiology, peripheral, and neurology. Curatia's product portfolio includes CE and US FDA approved vascular access devices such as URSA angiographic catheters, Xcess guiding catheter, NAVAJO PTA balloon catheter, Autoseal hemostasis valve kit, VELA RX dilatation balloon catheter, and EXTesia introducer sheath set. Additionally, the company offers OEM manufacturing for its customers. The company's activities are not limited to its own brand as it also provides OEM manufacturing for its clients. Having secured an Angel Round investment on July 21, 2022 from 天津海达创业投资管理有限公司 (Tianjin Haitong Venture Investment Management Co., Ltd.), Curatia Medical's success can be attributed to its commitment to innovation and product excellence. With the FDA registration process underway for the HW-Flex Distal Access Catheter, the company continues to expand its product offerings, positioning itself as a key player in the global medical device market. For more details on Curatia Medical's technology and products, interested parties can visit its website or contact the sales team at [email protected].
No recent news or press coverage available for Curatia Medical.